BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2010
View Archived Issues
Albert Einstein College of Medicine claims hypoxia-targeted agents
Read More
Effect of citalopram on drinking depends on goals of alcohol-dependent subjects
Read More
RespiVert claims MAPK p38 inhibitors
Read More
AstraZeneca discovers new inhibitors of DAT and NET
Read More
Histamine H3 receptor ligands claimed by Merck & Co.
Read More
Merck & Co. claims new glucagon receptor antagonists
Read More
Nerviano describes new B-raf kinase inhibitors
Read More
BHT-3021 shows promise in phase I/II trial in type 1 diabetes
Read More
Weekly rituximab reduces proteinuria in idiopathic membranous nephropathy
Read More
Exelixis presents preclinical data on agents investigated for diabetes
Read More
Viamet describes new cytochrome P450-C17 inhibitors
Read More
Western States Biopharma and University of Colorado to develop TCISM-targeting agents
Read More
Selvita and Orion collaborate on SEL-103 program in AD
Read More
KAEL-GemVax reports phase III data on tertomotide in pancreatic cancer
Read More
Imiquimod superior to placebo in phase III program for external genital warts
Read More
Results reported from phase II study of gemcitabine/Amplimexon in pancreatic cancer
Read More
Midatech and Immunotope join to form Syntara to develop immune therapies
Read More
Adimab and Novartis partner after launch of antibody discovery platform
Read More
Interim phase IIb data reported on TMC-435 in HCV infection
Read More
FDA accepts Protalix's NDA for taliglucerase alfa
Read More
Hemispherx reports on Japanese trials of nasal H5N1 vaccine
Read More
JDRF awards Biodel grants for its VIAject diabetes therapy
Read More
Mesoblast and FDA to discuss phase III program for bone marrow regeneration
Read More
Quest PharmaTech forms clinical advisory panel for oregovomab
Read More
Clinuvel reports on phase III trial of Scenesse in EPP
Read More